 | • レポートコード：B-GIR08C2628 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、血友病治療の世界市場について調べ、まとめました。種類別セグメントは、血友病A、血友病B等、用途別セグメントは、商業、軍事、政府、その他等に区分しました。血友病治療の世界市場概観、企業動向、企業別血友病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・血友病治療の市場概観 ・血友病治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・血友病治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・血友病治療の世界市場規模 ・血友病治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・血友病治療のアメリカ市場規模推移 ・血友病治療のカナダ市場規模推移 ・血友病治療のメキシコ市場規模推移 ・血友病治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・血友病治療のドイツ市場規模推移 ・血友病治療のイギリス市場規模推移 ・血友病治療のロシア市場規模推移 ・血友病治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・血友病治療の日本市場規模推移 ・血友病治療の中国市場規模推移 ・血友病治療の韓国市場規模推移 ・血友病治療のインド市場規模推移 ・血友病治療の東南アジア市場規模推移 ・血友病治療の南米市場分析（ブラジル、アルゼンチン等） ・血友病治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・血友病治療の種類別分析/販売量、売上、市場シェア（血友病A、血友病B） ・血友病治療の用途別分析/市場規模（商業、軍事、政府、その他） ・血友病治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・血友病治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Haemophilia is a mostly inherited genetic disorder that impairs the body’s ability to make blood clots, a process needed to stop bleeding.
Scope of the Report:
The worldwide market for Haemophilia Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Haemophilia Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bayer
Novo Nordisk
Pfizer
Roche
Aptevo Therapeutics
Catalyst BioSciences
Dimension Therapeutics
Shire
CSL Behring
Alnylam Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Haemophilia A
Haemophilia B
Market Segment by Applications, can be divided into
Hospital
Pharmaceutical Companies
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Haemophilia Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Haemophilia Treatment, with price, sales, revenue and global market share of Haemophilia Treatment in 2017 and 2018.
Chapter 3, the Haemophilia Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Haemophilia Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Haemophilia Treatment market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Haemophilia Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Haemophilia Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Haemophilia A
1.2.2 Haemophilia B
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Pharmaceutical Companies
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Haemophilia Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novo Nordisk
2.2.1 Business Overview
2.2.2 Haemophilia Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novo Nordisk Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Haemophilia Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Roche
2.4.1 Business Overview
2.4.2 Haemophilia Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Aptevo Therapeutics
2.5.1 Business Overview
2.5.2 Haemophilia Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Aptevo Therapeutics Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Catalyst BioSciences
2.6.1 Business Overview
2.6.2 Haemophilia Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Catalyst BioSciences Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Dimension Therapeutics
2.7.1 Business Overview
2.7.2 Haemophilia Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Dimension Therapeutics Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Shire
2.8.1 Business Overview
2.8.2 Haemophilia Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Shire Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 CSL Behring
2.9.1 Business Overview
2.9.2 Haemophilia Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 CSL Behring Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Alnylam Pharmaceuticals
2.10.1 Business Overview
2.10.2 Haemophilia Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Alnylam Pharmaceuticals Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Haemophilia Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Haemophilia Treatment Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Haemophilia Treatment Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Haemophilia Treatment Manufacturer Market Share in 2018
3.3.2 Top 6 Haemophilia Treatment Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Haemophilia Treatment Market Analysis by Regions
4.1 Global Haemophilia Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Haemophilia Treatment Sales and Market Share by Regions (2014-2019)
4.1.2 Global Haemophilia Treatment Revenue and Market Share by Regions (2014-2019)
4.2 North America Haemophilia Treatment Sales and Growth Rate (2014-2019)
4.3 Europe Haemophilia Treatment Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Haemophilia Treatment Sales and Growth Rate (2014-2019)
4.5 South America Haemophilia Treatment Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Haemophilia Treatment Sales and Growth Rate (2014-2019)
5 North America Haemophilia Treatment by Country
5.1 North America Haemophilia Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Haemophilia Treatment Sales and Market Share by Country (2014-2019)
5.1.2 North America Haemophilia Treatment Revenue and Market Share by Country (2014-2019)
5.2 United States Haemophilia Treatment Sales and Growth Rate (2014-2019)
5.3 Canada Haemophilia Treatment Sales and Growth Rate (2014-2019)
5.4 Mexico Haemophilia Treatment Sales and Growth Rate (2014-2019)
6 Europe Haemophilia Treatment by Country
6.1 Europe Haemophilia Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Haemophilia Treatment Sales and Market Share by Country (2014-2019)
6.1.2 Europe Haemophilia Treatment Revenue and Market Share by Country (2014-2019)
6.2 Germany Haemophilia Treatment Sales and Growth Rate (2014-2019)
6.3 UK Haemophilia Treatment Sales and Growth Rate (2014-2019)
6.4 France Haemophilia Treatment Sales and Growth Rate (2014-2019)
6.5 Russia Haemophilia Treatment Sales and Growth Rate (2014-2019)
6.6 Italy Haemophilia Treatment Sales and Growth Rate (2014-2019)
7 Asia-Pacific Haemophilia Treatment by Country
7.1 Asia-Pacific Haemophilia Treatment Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Haemophilia Treatment Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Haemophilia Treatment Revenue and Market Share by Country (2014-2019)
7.2 China Haemophilia Treatment Sales and Growth Rate (2014-2019)
7.3 Japan Haemophilia Treatment Sales and Growth Rate (2014-2019)
7.4 Korea Haemophilia Treatment Sales and Growth Rate (2014-2019)
7.5 India Haemophilia Treatment Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Haemophilia Treatment Sales and Growth Rate (2014-2019)
8 South America Haemophilia Treatment by Country
8.1 South America Haemophilia Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Haemophilia Treatment Sales and Market Share by Country (2014-2019)
8.1.2 South America Haemophilia Treatment Revenue and Market Share by Country (2014-2019)
8.2 Brazil Haemophilia Treatment Sales and Growth Rate (2014-2019)
8.3 Argentina Haemophilia Treatment Sales and Growth Rate (2014-2019)
8.4 Colombia Haemophilia Treatment Sales and Growth Rate (2014-2019)
9 Middle East and Africa Haemophilia Treatment by Countries
9.1 Middle East and Africa Haemophilia Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Haemophilia Treatment Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Haemophilia Treatment Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Haemophilia Treatment Sales and Growth Rate (2014-2019)
9.3 Turkey Haemophilia Treatment Sales and Growth Rate (2014-2019)
9.4 Egypt Haemophilia Treatment Sales and Growth Rate (2014-2019)
9.5 Nigeria Haemophilia Treatment Sales and Growth Rate (2014-2019)
9.6 South Africa Haemophilia Treatment Sales and Growth Rate (2014-2019)
10 Global Haemophilia Treatment Market Segment by Type
10.1 Global Haemophilia Treatment Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Haemophilia Treatment Sales and Market Share by Type (2014-2019)
10.1.2 Global Haemophilia Treatment Revenue and Market Share by Type (2014-2019)
10.2 Haemophilia A Sales Growth and Price
10.2.1 Global Haemophilia A Sales Growth (2014-2019)
10.2.2 Global Haemophilia A Price (2014-2019)
10.3 Haemophilia B Sales Growth and Price
10.3.1 Global Haemophilia B Sales Growth (2014-2019)
10.3.2 Global Haemophilia B Price (2014-2019)
11 Global Haemophilia Treatment Market Segment by Application
11.1 Global Haemophilia Treatment Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Pharmaceutical Companies Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Haemophilia Treatment Market Forecast (2019-2024)
12.1 Global Haemophilia Treatment Sales, Revenue and Growth Rate (2019-2024)
12.2 Haemophilia Treatment Market Forecast by Regions (2019-2024)
12.2.1 North America Haemophilia Treatment Market Forecast (2019-2024)
12.2.2 Europe Haemophilia Treatment Market Forecast (2019-2024)
12.2.3 Asia-Pacific Haemophilia Treatment Market Forecast (2019-2024)
12.2.4 South America Haemophilia Treatment Market Forecast (2019-2024)
12.2.5 Middle East and Africa Haemophilia Treatment Market Forecast (2019-2024)
12.3 Haemophilia Treatment Market Forecast by Type (2019-2024)
12.3.1 Global Haemophilia Treatment Sales Forecast by Type (2019-2024)
12.3.2 Global Haemophilia Treatment Market Share Forecast by Type (2019-2024)
12.4 Haemophilia Treatment Market Forecast by Application (2019-2024)
12.4.1 Global Haemophilia Treatment Sales Forecast by Application (2019-2024)
12.4.2 Global Haemophilia Treatment Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Haemophilia Treatment Picture
Table Product Specifications of Haemophilia Treatment
Figure Global Sales Market Share of Haemophilia Treatment by Types in 2018
Table Haemophilia Treatment Types for Major Manufacturers
Figure Haemophilia A Picture
Figure Haemophilia B Picture
Figure Haemophilia Treatment Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Pharmaceutical Companies Picture
Figure Other Picture
Figure United States Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure France Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure UK Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure China Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure India Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Haemophilia Treatment Revenue (Value) and Growth Rate (2014-2024)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Haemophilia Treatment Type and Applications
Table Bayer Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Haemophilia Treatment Type and Applications
Table Novo Nordisk Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Haemophilia Treatment Type and Applications
Table Pfizer Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Haemophilia Treatment Type and Applications
Table Roche Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Aptevo Therapeutics Basic Information, Manufacturing Base and Competitors
Table Aptevo Therapeutics Haemophilia Treatment Type and Applications
Table Aptevo Therapeutics Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Catalyst BioSciences Basic Information, Manufacturing Base and Competitors
Table Catalyst BioSciences Haemophilia Treatment Type and Applications
Table Catalyst BioSciences Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Dimension Therapeutics Basic Information, Manufacturing Base and Competitors
Table Dimension Therapeutics Haemophilia Treatment Type and Applications
Table Dimension Therapeutics Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Haemophilia Treatment Type and Applications
Table Shire Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CSL Behring Basic Information, Manufacturing Base and Competitors
Table CSL Behring Haemophilia Treatment Type and Applications
Table CSL Behring Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alnylam Pharmaceuticals Haemophilia Treatment Type and Applications
Table Alnylam Pharmaceuticals Haemophilia Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Haemophilia Treatment Sales by Manufacturer (2017-2018)
Figure Global Haemophilia Treatment Sales Market Share by Manufacturer in 2017
Figure Global Haemophilia Treatment Sales Market Share by Manufacturer in 2018
Table Global Haemophilia Treatment Revenue by Manufacturer (2017-2018)
Figure Global Haemophilia Treatment Revenue Market Share by Manufacturer in 2017
Figure Global Haemophilia Treatment Revenue Market Share by Manufacturer in 2018
Figure Top 3 Haemophilia Treatment Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Haemophilia Treatment Manufacturer (Revenue) Market Share in 2018
Figure Global Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Global Haemophilia Treatment Revenue and Growth Rate (2014-2019)
Table Global Haemophilia Treatment Sales by Regions (2014-2019)
Table Global Haemophilia Treatment Sales Market Share by Regions (2014-2019)
Table Global Haemophilia Treatment Revenue by Regions (2014-2019)
Figure Global Haemophilia Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Haemophilia Treatment Revenue Market Share by Regions in 2018
Figure North America Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Europe Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure South America Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure North America Haemophilia Treatment Revenue and Growth Rate (2014-2019)
Table North America Haemophilia Treatment Sales by Countries (2014-2019)
Table North America Haemophilia Treatment Sales Market Share by Countries (2014-2019)
Figure North America Haemophilia Treatment Sales Market Share by Countries (2014-2019)
Figure North America Haemophilia Treatment Sales Market Share by Countries in 2018
Table North America Haemophilia Treatment Revenue by Countries (2014-2019)
Table North America Haemophilia Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Haemophilia Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Haemophilia Treatment Revenue Market Share by Countries in 2018
Figure United States Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Canada Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Mexico Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Europe Haemophilia Treatment Revenue and Growth Rate (2014-2019)
Table Europe Haemophilia Treatment Sales by Countries (2014-2019)
Table Europe Haemophilia Treatment Sales Market Share by Countries (2014-2019)
Table Europe Haemophilia Treatment Revenue by Countries (2014-2019)
Figure Europe Haemophilia Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Haemophilia Treatment Revenue Market Share by Countries in 2018
Figure Germany Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure UK Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure France Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Russia Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Italy Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Haemophilia Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Haemophilia Treatment Sales by Countries (2014-2019)
Table Asia-Pacific Haemophilia Treatment Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Haemophilia Treatment Sales Market Share by Countries 2018
Table Asia-Pacific Haemophilia Treatment Revenue by Countries (2014-2019)
Figure Asia-Pacific Haemophilia Treatment Revenue Market Share by Countries 2018
Figure China Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Japan Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Korea Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure India Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Southeast Asia Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure South America Haemophilia Treatment Revenue and Growth Rate (2014-2019)
Table South America Haemophilia Treatment Sales by Countries (2014-2019)
Table South America Haemophilia Treatment Sales Market Share by Countries (2014-2019)
Figure South America Haemophilia Treatment Sales Market Share by Countries in 2018
Table South America Haemophilia Treatment Revenue by Countries (2014-2019)
Table South America Haemophilia Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Haemophilia Treatment Revenue Market Share by Countries in 2018
Figure Brazil Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Argentina Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Colombia Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Haemophilia Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Haemophilia Treatment Sales by Countries (2014-2019)
Table Middle East and Africa Haemophilia Treatment Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Haemophilia Treatment Sales Market Share by Countries in 2018
Table Middle East and Africa Haemophilia Treatment Revenue by Countries (2014-2019)
Table Middle East and Africa Haemophilia Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Haemophilia Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Haemophilia Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure UAE Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Egypt Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure Nigeria Haemophilia Treatment Sales and Growth Rate (2014-2019)
Figure South Africa Haemophilia Treatment Sales and Growth Rate (2014-2019)
Table Global Haemophilia Treatment Sales by Type (2014-2019)
Table Global Haemophilia Treatment Sales Share by Type (2014-2019)
Table Global Haemophilia Treatment Revenue by Type (2014-2019)
Table Global Haemophilia Treatment Revenue Share by Type (2014-2019)
Figure Global Haemophilia A Sales Growth (2014-2019)
Figure Global Haemophilia A Price (2014-2019)
Figure Global Haemophilia B Sales Growth (2014-2019)
Figure Global Haemophilia B Price (2014-2019)
Table Global Haemophilia Treatment Sales by Application (2014-2019)
Table Global Haemophilia Treatment Sales Share by Application (2014-2019)
Figure Global Pharmaceutical Companies Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Haemophilia Treatment Sales, Revenue and Growth Rate (2019-2024)
Table Global Haemophilia Treatment Sales Forecast by Regions (2019-2024)
Table Global Haemophilia Treatment Market Share Forecast by Regions (2019-2024)
Figure North America Sales Haemophilia Treatment Market Forecast (2019-2024)
Figure Europe Sales Haemophilia Treatment Market Forecast (2019-2024)
Figure Asia-Pacific Sales Haemophilia Treatment Market Forecast (2019-2024)
Figure South America Sales Haemophilia Treatment Market Forecast (2019-2024)
Figure Middle East and Africa Sales Haemophilia Treatment Market Forecast (2019-2024)
Table Global Haemophilia Treatment Sales Forecast by Type (2019-2024)
Table Global Haemophilia Treatment Market Share Forecast by Type (2019-2024)
Table Global Haemophilia Treatment Sales Forecast by Application (2019-2024)
Table Global Haemophilia Treatment Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
ムコ多糖症（MPS）治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Mucopolysaccharidoses are a group of metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes needed to break down molecules called glycosaminoglycans. These long chains of sugar carbohydrates occur within the cells that help build bone, cartilage, tendons, corneas, skin and …- 世界の獣医整形外科治療市場：市場規模・現状・予測 Animals commonly suffer from different orthopedic conditions that result in abnormal movement, instability, lameness, and others. Orthopedic conditions such as hip dysplasia, elbow dysplasia, patella luxation, and others require a surgical procedure for the treatment of the condition. The treatment …
- 便秘治療薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Constipation Treatment Drug is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Constipation Treatmen…
- ドナーエッグIVF治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Donor Egg IVF Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…
- オピオイド耐性治療の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Opioids are effective analgesics prescribed to people with chronic cancer and severe pain. These opioids are generally used for short period of time. If these opioids are prescribed or taken for a longer period of time or more frequent daily doses, they create opioid tolerance in patients and hence,…